Trial intelligence / Profile preview

Oral zinc for hyperbilirubinemia in low birth weight premature neonates

IRCT201401041162N22Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of zinc in hyperbilirubinemia and low birth weight (LBW), sponsored by Mashhad University of Medical Sciences. Started May 2014; status: completed.

02

Drugs

zinc
03

Conditions

hyperbilirubinemialow birth weight (LBW)

Beyond the preview

Go deeper on IRCT201401041162N22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201401041162N22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call